اخبار و اعلانات

 آمار

تعداد نشریات283
تعداد نشریات سازمان81
تعداد شماره‌ها2,726
تعداد مقالات31,041
تعداد مشاهده مقاله27,848,588
تعداد دریافت فایل اصل مقاله16,230,413
Mushtaq Hashim Al-Bderee, N, Faaz Nassir Al-Saad, N, Jawad Al-Imari, M, Mudhaher Habbeb, S, Mizal Azoz, A. (1401). Genetic Polymorphisms of NOD2 and ATG16L1 in Different Types of Digestive Tract Inflammation. سامانه مدیریت نشریات علمی, 78(1), 493-498. doi: 10.22092/ari.2022.359754.2473
N Mushtaq Hashim Al-Bderee; N Faaz Nassir Al-Saad; M Jawad Al-Imari; S Mudhaher Habbeb; A Mizal Azoz. "Genetic Polymorphisms of NOD2 and ATG16L1 in Different Types of Digestive Tract Inflammation". سامانه مدیریت نشریات علمی, 78, 1, 1401, 493-498. doi: 10.22092/ari.2022.359754.2473
Mushtaq Hashim Al-Bderee, N, Faaz Nassir Al-Saad, N, Jawad Al-Imari, M, Mudhaher Habbeb, S, Mizal Azoz, A. (1401). 'Genetic Polymorphisms of NOD2 and ATG16L1 in Different Types of Digestive Tract Inflammation', سامانه مدیریت نشریات علمی, 78(1), pp. 493-498. doi: 10.22092/ari.2022.359754.2473
Mushtaq Hashim Al-Bderee, N, Faaz Nassir Al-Saad, N, Jawad Al-Imari, M, Mudhaher Habbeb, S, Mizal Azoz, A. Genetic Polymorphisms of NOD2 and ATG16L1 in Different Types of Digestive Tract Inflammation. سامانه مدیریت نشریات علمی, 1401; 78(1): 493-498. doi: 10.22092/ari.2022.359754.2473

Genetic Polymorphisms of NOD2 and ATG16L1 in Different Types of Digestive Tract Inflammation

Archives of Razi Institute
مقاله 61، دوره 78، شماره 1، فروردین و اردیبهشت 2023، صفحه 493-498    اصل مقاله (380.85 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2022.359754.2473
نویسندگان
N Mushtaq Hashim Al-Bderee* 1؛ N Faaz Nassir Al-Saad1؛ M Jawad Al-Imari2؛ S Mudhaher Habbeb1؛ A Mizal Azoz1
1Medical Biotechnology Department, College of Biotechnology, Al-Qasim Green University, Babylon Province, Iraq
2Department of Medical Laboratory Techniques, Al-Mustaqbal University College, 51001 Hillah, Babylon, Iraq
چکیده
Inflammatory bowel diseases (IBD) result from genetic and environmental factors. The two clinical manifestations of inflammatory bowel disease are ulcerative colitis and Crohn's disease (IBD). Numerous studies have demonstrated a link between immune system molecules' single nucleotide polymorphisms (SNPs) and the incidence of IBD. The study aimed to examine the potential impact of the SNPs NOD2 rs2066844 and ATG16L1 rs2241880 in a group sample of Iraqi IBD patients. The AG genotype for rs2241880 was associated with an increased risk for CD (P=0.1) and a negative association with UC, whereas the AA genotype presents less in CD patients and a negative association with UC (P=0.89). For this SNP, the G allele was associated with the risk of CD but not for UC. For the rs2066844, there were no significant differences for NOD2 in both CD and UC, and associations between variation and diseases were not observed.
کلیدواژه‌ها
NOD2؛ ATG16L1؛ Crohn's Disease؛ Ulcerative Colitis
سایر فایل های مرتبط با مقاله
مراجع
  1. Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578(7796):527-39.
  2. Mitsialis V, Wall S, Liu P, Ordovas-Montanes J, Parmet T, Vukovic M, et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease. Gastroenterology. 2020;159(2):591-608. e10.
  3. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-24.
  4. Weiser M, Simon JM, Kochar B, Tovar A, Israel JW, Robinson A, et al. Molecular classification of Crohn's disease reveals two clinically relevant subtypes. Gut. 2018;67(1):36-42.
  5. Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol. 2019;16(5):296-311.
  6. Boukercha A, Mesbah-Amroun H, Bouzidi A, Saoula H, Nakkemouche M, Roy M, et al. NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease. World J Gastroenterol. 2015;21(25):7786.
  7. Iida T, Onodera K, Nakase H. Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2017;23(11):1944.
  8. Sidiq T, Yoshihama S, Downs I, Kobayashi KS. Nod2: a critical regulator of ileal microbiota and Crohn’s disease. Front Immunol. 2016;7:367.
  9. Pranculienė G, Steponaitienė R, Skiecevičienė J, Kučinskienė R, Kiudelis G, Adamonis K, et al. Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population. Medicina. 2016;52(6):325-30.
  10. Wang S-L, Shao B-Z, Zhao S-B, Fang J, Gu L, Miao C-Y, et al. Impact of paneth cell autophagy on inflammatory bowel disease. Front Immunol. 2018;9:693.
  11. Nuij V, Peppelenbosch M, van der Woude C, Fuhler G. Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease. J Transl Med. 2017;15(1):1-8.
  12. Salem M, Ammitzboell M, Nys K, Seidelin JB, Nielsen OH. ATG16L1: a multifunctional susceptibility factor in Crohn disease. Autophagy. 2015;11(4):585-94.
  1. Al-Mousawi HTM, Mushtaq A-BN, Bohan AH. Molecular and immunological activity of Terminalia chebula extracts.
  2. West NR, Hegazy AN, Owens BM, Bullers SJ, Linggi B, Buonocore S, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23(5):579-89.
  3. AL-Saad NF, Nadhim M, Nawar H. Serological, culture and urea breath test for detection of H. Pylori in gastric ulcers patients. Indian J Med Forensic Med Toxicol. 2020;14(4):1317-22.
  4. Hoffmann P, Lamerz D, Hill P, Kirchner M, Gauss A. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn’s Disease: On the Way to Personalized Medicine? Genes. 2021;12(6):866.
  5. Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw. 2017;17(1):25-40.
  6. Al Nabhani Z, Dietrich G, Hugot J-P, Barreau F. Nod2: The intestinal gate keeper. PLoS pathogens. 2017;13(3):e1006177.
  7. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006;6(1):9-20.
  8. Jakopin Z. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway. J Med Chem. 2014;57(16):6897-918.
  9. Műzes G, Tulassay Z, Sipos F. Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature. World J Gastroenterol. 2013;19(28):4447.
  10. Bank S, Andersen PS, Burisch J, Pedersen N, Roug S, Galsgaard J, et al. Polymorphisms in the toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort. PLoS One. 2015;10(12):e0145302.
  11. Török HP, Bellon V, Konrad A, Lacher M, Tonenchi L, Siebeck M, et al. Functional Toll-Like Receptor (TLR) 2 polymorphisms in the susceptibility to inflammatory bowel disease. PLoS One. 2017;12(4):e0175180.
آمار
تعداد مشاهده مقاله: 999
تعداد دریافت فایل اصل مقاله: 249


counter
سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب